COSCIENS Biopharma (CSCI)

Profile

Full Name

COSCIENS Biopharma Inc.

Ticker Symbol

CSCI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

July 18, 1996

Indexes

Not included

Website

http://www.cosciensbio.com

Employees

21

Key Details

Price

$2.91(+2.11%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.26M(-47.69% YoY)

Annual EPS

-$1.92(-202.31% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.91
CSCI price is $2.91

30-Day Relative Volume

0.04
CSCI 30-day relative volume is 0.04

Price Performance

Price Most recent change

+2.11%
CSCI price was up +2.11% on Apr 14, 2025

Price YTD change

+5.05%
CSCI price is up +5.05% since January 1st

Price 1-year change

-63.26%
CSCI price is down -63.26% year-on-year

Price 3-year change

-91.18%
CSCI price is down -91.18% over the past 3 years

Price Range

Price All-time high

$690000.00
CSCI price is currently -100.00% below its historical high of $690000.00

Price 3-year low

$1.96
CSCI price is currently +48.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.09M
CSCI market capitalization is $9.09 million

Market cap 3-year change

-84.98%
CSCI market capitalization is down -84.98% over the past 3 years

Market cap All-time high

$400.10B
CSCI market capitalization is currently -100.00% below its historical high of $400.10 billion

Market cap sector rank

18.75%
CSCI market capitalization is higher than 18.75% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+69.05%
CSCI shares outstanding is up +69.05% year-on-year

Shares Outstanding 3-Year Change

+70.37%
CSCI shares outstanding is up +70.37% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
CSCI beta is 0.86

200-day SMA

$3.74
CSCI price is currently -22.21% below its 200-day simple moving average

50-day SMA

$2.88
CSCI price is currently +1.04% above its 50-day simple moving average

RSI

50.71
CSCI 14-day relative strength index is 50.71

Volume

0.04
CSCI 30-day relative volume is 0.04

ATR

$0.31
CSCI average true range is $0.31

10-day Historical Volatility

100.16%
CSCI 10-day historical volatility is 100.16%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$7.26M
CSCI annual revenue is $7.26 million

Revenue Analysts estimate

$4.30M
CSCI annual revenue is currently +68.88% higher than the consensus analysts' forecast

Revenue 1-year change

-47.69%
CSCI annual revenue is down -47.69% year-on-year

Revenue Sector rank

24.3%
CSCI annual revenue is higher than 24.3% of companies in Healthcare sector

EPS

EPS

-$1.92
CSCI annual earnings per share is -$1.92

EPS Analysts estimate

-
CSCI annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-202.31%
CSCI annual earnings per share is down -202.31% year-on-year

EPS Sector rank

39.62%
CSCI annual earnings per share is higher than 39.62% of companies in Healthcare sector

Profit

Gross profit

$2.93M
CSCI annual gross profit is $2.93 million

Gross margin

41.07%
CSCI annual gross profit margin is 41.07%

Operating profit

-$18.01M
CSCI annual operating income is -$18.01 million

Operating margin

-400.36%
CSCI annual operating profit margin is -400.36%

Net income

-$3.55M
CSCI annual net profit is -$3.55 million

Net margin

-48.89%
CSCI annual net profit margin is -48.89%

Expenses

Total expenses

$22.51M
CSCI annual total expenses is $22.51 million

Operating expenses

$22.28M
CSCI annual total operating expenses is $22.28 million

Cost of goods sold

$4.20M
CSCI annual cost of goods sold is $4.20 million

Selling, general & administrative expenses

$5.52M
CSCI annual SGA is $5.52 million

Depreciation and amortization

$169.00K
CSCI annual depreciation & amortization is $169.00 thousand

Interest expense

$96.60K
CSCI annual interest expense is $96.60 thousand

Income tax

-$900.60K
CSCI annual income tax is -$900.60 thousand

EBIT & EBITDA

EBIT

-$18.01M
CSCI annual earnings before interest & taxes is -$18.01 million

EBITDA

-$17.84M
CSCI annual EBITDA is -$17.84 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$23.70M
CSCI annual total assets is $23.70 million

Non current assets

$649.00K
CSCI annual long term assets is $649.00 thousand

Current assets

$36.37M
CSCI annual total current assets is $36.37 million

Cash and cash equivalents

$34.02M
CSCI annual cash & cash equivalents is $34.02 million

Accounts receivable

$126.10K
CSCI annual accounts receivable is $126.10 thousand

Inventory

$4.00M
CSCI annual inventory is $4.00 million

Liabilities

Total liabilities

$2.71M
CSCI annual total liabilities is $2.71 million

Long term liabilities

$1.40M
CSCI annual total long term liabilities is $1.40 million

Current liabilities

$4.54M
CSCI annual total current liabilities is $4.54 million

Accounts payable

$1.87M
CSCI annual accounts payable is $1.87 million

Debt

Total debt

$1.70M
CSCI annual total debt is $1.70 million

Total debt 1-year change

-12.17%
CSCI annual total debt is down -12.17% year-on-year

Long term debt

$1.40M
CSCI annual long term debt is $1.40 million

Short term debt

$298.70K
CSCI annual short term debt is $298.70 thousand

Equity & Capital

Shareholders equity

$21.00M
CSCI annual stockholders equity is $21.00 million

Book value

$18.20M
CSCI annual book value is $18.20 million

Retained earnings

-$369.83M
CSCI annual retained earnings is -$369.83 million

Working capital

$31.83M
CSCI annual working capital is $31.83 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$17.12M
CSCI annual cash flow from operations is -$17.12 million

Cash from operations 1-year change

-25.13%
CSCI annual cash flow from operations is down -25.13% year-on-year

Cash from investing

$528.00K
CSCI annual cash flow from investing activities is $528.00 thousand

Cash from investing 1-year change

+4500%
CSCI annual cash flow from investing activities is up +4500% year-on-year

Cash from financing

-$151.00K
CSCI annual cash flow from financing activities is -$151.00 thousand

Cash from financing 1-year change

-27.97%
CSCI annual cash flow from financing activities is down -27.97% year-on-year

CAPEX

CAPEX

$726.30K
CSCI annual capital expenditures is $726.30 thousand

CAPEX 1-year change

+142.99%
CSCI annual capital expenditures is up +142.99% year-on-year

Free Cash Flow

Free cash flow

-$17.14M
CSCI annual free cash flow is -$17.14 million

Free cash flow 1-year change

-25.17%
CSCI annual free cash flow is down -25.17% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

41.07%
CSCI annual gross profit margin is 41.07%

Operating margin

-400.36%
CSCI annual operating profit margin is -400.36%

Net margin

-48.89%
CSCI annual net profit margin is -48.89%

ROA & ROE

ROA

-13.79%
CSCI annual return on assets is -13.79%

ROE

-15.85%
CSCI annual return on equity is -15.85%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CSCI price to earnings ratio value is unknown

PE ratio Sector rank

-
CSCI price to earnings ratio is unknown

PB Ratio

PB ratio

0.45
CSCI price to book ratio is 0.45

PB ratio Sector rank

28.23%
CSCI price to book ratio is higher than 28.23% of companies in Healthcare sector

PS Ratio

PS ratio

1.20
CSCI price to sales ratio is 1.20

PS ratio Sector rank

30.64%
CSCI price to sales ratio is higher than 30.64% of companies in Healthcare sector

Enterprise value

Enterprise value

-$9.29M
CSCI enterprise value is -$9.29 million

Enterprise value Sector rank

5.04%
CSCI enterprise value is higher than 5.04% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.94
CSCI EV/EBITDA is 0.94

EV/EBITDA Sector rank

74.61%
CSCI EV/EBITDA is higher than 74.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.01
CSCI annual current ratio is 8.01

Quick ratio

7.13
CSCI annual quick ratio is 7.13

Leverage

Debt to equity

0.00
CSCI annual debt to equity ratio is 0.00

Interest coverage ratio

-186.42
CSCI annual interest coverage ratio is -186.42

Risk & Stability

Piotroski F-Score

2
CSCI piotroski f-score is 2

Altman Z-Score

-20.42
CSCI altman z-score is -20.42

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

Neuphoria Therapeutics (NEUP)
BCDA logo
BioCardia (BCDA)
HOOK logo
HOOKIPA Pharma (HOOK)
BIAF logo
bioAffinity Technologies (BIAF)
NURO logo
NeuroMetrix (NURO)
FLGC logo
Flora Growth (FLGC)
EVAX logo
Evaxion Biotech A/S (EVAX)
AIMD logo
Ainos (AIMD)
CARM logo
Carisma Therapeutics (CARM)
  • What is the ticker symbol for COSCIENS Biopharma?
  • Does COSCIENS Biopharma pay dividends?
  • What sector is COSCIENS Biopharma in?
  • What industry is COSCIENS Biopharma in?
  • What country is COSCIENS Biopharma based in?
  • When did COSCIENS Biopharma go public?
  • Is COSCIENS Biopharma in the S&P 500?
  • Is COSCIENS Biopharma in the NASDAQ 100?
  • Is COSCIENS Biopharma in the Dow Jones?
  • When was COSCIENS Biopharma's last earnings report?
  • When does COSCIENS Biopharma report earnings?

What is the ticker symbol for COSCIENS Biopharma?

The ticker symbol for COSCIENS Biopharma is NASDAQ:CSCI

Does COSCIENS Biopharma pay dividends?

No, COSCIENS Biopharma does not pay dividends

What sector is COSCIENS Biopharma in?

COSCIENS Biopharma is in the Healthcare sector

What industry is COSCIENS Biopharma in?

COSCIENS Biopharma is in the Biotechnology industry

What country is COSCIENS Biopharma based in?

COSCIENS Biopharma is headquartered in Canada

When did COSCIENS Biopharma go public?

COSCIENS Biopharma's initial public offering (IPO) was on July 18, 1996

Is COSCIENS Biopharma in the S&P 500?

No, COSCIENS Biopharma is not included in the S&P 500 index

Is COSCIENS Biopharma in the NASDAQ 100?

No, COSCIENS Biopharma is not included in the NASDAQ 100 index

Is COSCIENS Biopharma in the Dow Jones?

No, COSCIENS Biopharma is not included in the Dow Jones index

When was COSCIENS Biopharma's last earnings report?

COSCIENS Biopharma's most recent earnings report was on Aug 9, 2024

When does COSCIENS Biopharma report earnings?

The date for COSCIENS Biopharma's next earnings report has not been announced yet
On this page